These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27644153)

  • 1. CD4
    Li Z; Liu X; Guo R; Wang P
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):1-9. PubMed ID: 27644153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of regulatory characteristics in CD4
    Bian LQ; Mao L; Bi Y; Zhou SW; Chen ZD; Wen J; Shi J; Wang L
    APMIS; 2017 Dec; 125(12):1108-1116. PubMed ID: 28913840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.
    Levings MK; Sangregorio R; Sartirana C; Moschin AL; Battaglia M; Orban PC; Roncarolo MG
    J Exp Med; 2002 Nov; 196(10):1335-46. PubMed ID: 12438424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
    Jarnicki AG; Lysaght J; Todryk S; Mills KH
    J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characterization and role of regulatory T cells in immune reactions.
    Wilczynski JR; Radwan M; Kalinka J
    Front Biosci; 2008 Jan; 13():2266-74. PubMed ID: 17981708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.
    Levings MK; Sangregorio R; Galbiati F; Squadrone S; de Waal Malefyt R; Roncarolo MG
    J Immunol; 2001 May; 166(9):5530-9. PubMed ID: 11313392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of LAP
    Zhong W; Jiang ZY; Zhang L; Huang JH; Wang SJ; Liao C; Cai B; Chen LS; Zhang S; Guo Y; Cao YF; Gao F
    World J Gastroenterol; 2017 Jan; 23(3):455-463. PubMed ID: 28210081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma.
    Akasaki Y; Liu G; Chung NH; Ehtesham M; Black KL; Yu JS
    J Immunol; 2004 Oct; 173(7):4352-9. PubMed ID: 15383564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICOS
    Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
    Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta.
    Satoguina JS; Adjobimey T; Arndts K; Hoch J; Oldenburg J; Layland LE; Hoerauf A
    Eur J Immunol; 2008 Nov; 38(11):3101-13. PubMed ID: 18924213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells.
    He S; Li M; Ma X; Lin J; Li D
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2621-30. PubMed ID: 20930173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-β.
    Schmidt A; Zhang XM; Joshi RN; Iqbal S; Wahlund C; Gabrielsson S; Harris RA; Tegnér J
    Immunol Cell Biol; 2016 Sep; 94(8):747-62. PubMed ID: 27075967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
    Kristensen B
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy.
    Kumar S; Naqvi RA; Ali R; Rani R; Khanna N; Rao DN
    Mol Immunol; 2013 Dec; 56(4):513-20. PubMed ID: 23911408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
    Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
    Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17 facilitates the immune suppressor capacity of high-grade glioma-derived CD4 (+) CD25 (+) Foxp3 (+) T cells via releasing transforming growth factor beta.
    Liang H; Yi L; Wang X; Zhou C; Xu L
    Scand J Immunol; 2014 Aug; 80(2):144-50. PubMed ID: 24813240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells.
    Chevalier MF; Didier C; Petitjean G; Karmochkine M; Girard PM; Barré-Sinoussi F; Scott-Algara D; Weiss L
    J Infect Dis; 2015 Mar; 211(5):769-79. PubMed ID: 25281758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.